The federal comment period on how vaccine recommendations are labeled closed Sunday with 33,992 comments received at Regulations.gov, according to the Federal Register page for the request. That count reflects the final day of a 27-day window, and the total may change because agencies review submissions and may redact or withhold some of them.
The closing shifts the question for parents from whether to weigh in to what happens next. The input now goes to the Task Force on Safer Childhood Vaccines, which an Aug. 10 executive order directed to deliver plans for the childhood immunization schedule within 90 days, a deadline that falls in early November.
Nothing has changed yet at the pediatrician's office. The notice states that it does not alter any existing vaccine recommendation, coverage requirement, or program obligation. But the labels under review help determine how a vaccine is offered, how easily it is given and, for some families, whether a child gets it at all.
The Comment Count Is In, but the Decisions Are Not
The request for information, published Aug. 24, asked 18 questions about the three categories now used in federal recommendations. A routine recommendation means the default is to vaccinate everyone in an age group. A risk-based recommendation applies to people with specific conditions or exposures. Shared clinical decision-making, which HHS now also calls individual-based decision-making, has no default and leaves the choice to a clinician and a patient or parent, as the CDC explains.
The notice floated possible new labels, including a category for vaccines recommended but not during infancy, and asked whether shared clinical decision-making should be renamed a conditional recommendation. It did not name which vaccines might be placed in any new category.
Major questions remain open. HHS has not said which categories it will adopt, how many comments supported or opposed changes, or whether it will publish a summary, and the notice says the department will not respond to comments individually. Whether the task force's plans will be released publicly, and when, is also unconfirmed.
MedicalDaily previously reported on the approaching comment deadline and related insurance rules. Since then, the window has closed, and the next milestone is the task force's early November deadline.
A Label Can Change What Happens in the Exam Room
For families, the category is more than wording. Routine recommendations are built into health record prompts and standing orders, so a nurse or pharmacist can vaccinate without a separate discussion. Shared decision-making recommendations lack that default. A national survey of family physicians and internists, which the HHS notice also describes, found that 90% to 95% said these recommendations take more time, fewer than half knew the vaccines were covered by insurance, and many saw their electronic records display the recommendations incorrectly or not at all.
Federal data show what that gap can look like. In the CDC's 2025 National Immunization Survey-Teen, published Sept. 3, 90.8% of 17-year-olds had received at least one dose of the routinely recommended MenACWY meningococcal vaccine. For the MenB vaccine, recommended for ages 16 to 23 under shared clinical decision-making, 36.3% had at least one dose and 12.5% had at least two doses.
The comparison has limits. The two vaccines protect against different strains, MenACWY is required for school entry in most states, and the survey had a 21.4% response rate. The data show an association between the category and uptake, not proof that the label alone caused the gap.
"In a busy clinic, no default is a default," Dr. Jake Scott, a clinical associate professor of infectious diseases at Stanford University School of Medicine, wrote in a CIDRAP opinion piece urging clinicians to comment before the deadline.
Coverage is a separate concern. Under current rules, a shared clinical decision-making recommendation adopted by the CDC director carries the same no-cost coverage requirement under the Affordable Care Act and the same Vaccines for Children eligibility as a routine one. Families told a vaccine falls under shared decision-making can ask their plan to confirm coverage before the visit.
State and City Coverage Already Varies Widely
Any change in labels would land on uneven ground. The same CDC survey found that coverage with at least one dose of MenACWY ranged from 61.2% in Mississippi to 96.5% in Rhode Island. Among large cities sampled separately, coverage was 95.0% in Chicago, 94.0% in New York City, 92.6% in Philadelphia, 88.5% in Bexar County, which includes San Antonio, and 86.2% in Houston.
HPV vaccination, which is routinely recommended but required for school in a few states, varied even more. Coverage with at least one dose ranged from 49.5% in Mississippi to 94.1% in Rhode Island, and it was 12 percentage points lower in mostly rural areas than in mostly urban areas. Chicago (88.9%) and Philadelphia (87.8%) led the sampled cities, while Houston stood at 79.0% and Bexar County at 78.0%.
Those gaps suggest who could feel any change first: families in rural counties, households below the poverty line, and communities with fewer well-child visits, where CDC researchers already see lower coverage.
Families do not need to wait on the federal process. Parents can review a child's records with a pediatrician or pharmacist, ask which vaccines are due at the next visit, and confirm insurance coverage before an appointment. The public docket remains viewable on Regulations.gov.
Key Questions Answered
What closed on Sept. 20? The public comment period on an HHS request for information about the categories used in federal vaccine recommendations. The Federal Register showed 33,992 comments received at Regulations.gov on the final day.
Has any vaccine recommendation changed? No. The notice says it does not alter any recommendation, coverage requirement or program obligation.
What are the three current categories? Routine, which defaults to vaccinating everyone in an age group; risk-based, for people with specific conditions or exposures; and shared clinical decision-making, which has no default and is decided between a clinician and a patient or parent.
What happens next? The comments go to the Task Force on Safer Childhood Vaccines, which must deliver childhood schedule plans within 90 days of the Aug. 10 executive order, placing the deadline in early November.
Are shared decision-making vaccines covered by insurance? Under current rules, yes. Once adopted by the CDC director, they carry the same no-cost ACA coverage and Vaccines for Children eligibility as routine recommendations.
What should parents do now? Review a child's vaccine records with a pediatrician or pharmacist, ask which doses are due, and confirm coverage with the insurance plan before appointments.
